康宁杰瑞制药-B于2024年ESMO大会呈列的JSKN003的I期临床研究及I/II期临床研究的最新研究成果

新浪港股
16 Sep 2024

康宁杰瑞制药-B(09966)发布公告,在澳大利亚进行的JSKN003 治疗晚期/转移性实体瘤患者的I期临床研究(研究编号:JSKN003-101)(JSKN003-101),及在中国进行的JSKN003治疗晚期实体瘤患者的I/II期临床研究(研究编号:JSKN003-102)(JSKN003-102)的最新研究成果已于2024年 ESMO大会(一个面向世界各地的临床医生、研究人员、患者倡议者、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10